ARTHROPLASTY
AAOS2017: Blood loss and transfusion rate similar with intravenous and topical TXA in THA
124 patients undergoing primary, cementless total hip arthroplasty were included in this randomized controlled trial to compare the efficacy of different methods of tranexamic acid application. Patients were randomized to either intravenous administration of tranexamic acid 10 minutes prior to skin incision, or topical infiltration prior to skin closure. The results of this study indicated that there was no significant difference in perioperative blood loss, peak change in hemoglobin, or the number of transfusions required.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
